Abstract
Vaccines are medicines intended to produce a definite, active immune reaction in a host that will halt the onset of a disease or reduce the impact of a disease once it has instigated. In infectious illnesses state, almost every vaccine is given prophylactically. These techniques have offered a few of the most imperative improvements in human healthcare over the past century.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
A. Bianco, K. Kostarelos, M. Prato, Applications of carbon nanotubes in drug delivery. Curr. Opin. Chem. Biol. 9, 674–679 (2005)
M. Carbone, F. Valentini, R. Caminiti, A. Petrinca, D. Donia, M. Divizia, G. Palleschi, Are PEI-coated SWCNTs conjugated with hepatitis a virus? A Chemical study with SEM, Z-potential, EDXD and RT-PCR. Biomed. Mater. 5, 035001 (2010)
H. Dumortier, S. Lacotte, G. Pastorin, R. Marega, W. Wu, D. Bonifazi, J.-P. Briand, M. Prato, S. Muller, A. Bianco, Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Lett. 6, 1522–1528 (2006)
R. Dyall, W.B. Bowne, L.W. Weber, J. LeMaoult, P. Szabo, Y. Moroi, G. Piskun, J.J. Lewis, A.N. Houghton, J. Nikolić-Žugić, Heteroclitic immunization induces tumor immunity. J. Exp. Med. 188, 1553–1561 (1998)
A.M. Farkas, O.J. Finn, Vaccines based on abnormal self-antigens as tumor-associated antigens: immune regulation, in Seminars in Immunology (Elsevier, Amsterdam, 2010), pp 125–131
T. Fifis, A. Gamvrellis, B. Crimeen-Irwin, G.A. Pietersz, J. Li, P.L. Mottram, I.F. McKenzie, M. Plebanski, Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J. Immunol. 173, 3148–3154 (2004)
V. Georgakilas, N. Tagmatarchis, D. Pantarotto, A. Bianco, J-P. Briand, M. Prato, Amino acid functionalisation of water soluble carbon nanotubes. Chem. Commun. 3050–3051 (2002)
A. Heath, J. Playfair, Cytokines as immunological adjuvants. Vaccine 10, 427–434 (1992)
A.N. Houghton, J.A. Guevara-Patiño, Immune recognition of self in immunity against cancer. J. Clin. Investig. 114, 468–471 (2004)
N.W.S. Kam, M. O’Connell, J.A. Wisdom, H. Dai, Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl. Acad. Sci. 102, 11600–11605 (2005)
C. Kojima, Design of stimuli-responsive dendrimers. Expert Opin. Drug Deliv. 7, 307–319 (2010)
N.V. Konduru, Y.Y. Tyurina, W. Feng, L.V. Basova, N.A. Belikova, H. Bayir, K. Clark, M. Rubin, D. Stolz, H. Vallhov, Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo. Plos One 4, e4398 (2009)
K. Kostarelos, A. Bianco, M. Prato, Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 4, 627 (2009)
K. Kostarelos, L. Lacerda, G. Pastorin, W. Wu, S. Wieckowski, J. Luangsivilay, S. Godefroy, D. Pantarotto, J.-P. Briand, S. Muller, Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat. Nanotechnol. 2, 108 (2007)
P.O. Livingston, G. Ragupathi, Cancer vaccines targeting carbohydrate antigens. Hum. Vaccines 2, 137–143 (2006)
C.L. Mackall, Spreading the wealth: antigen discovery in adult tumors can help hone the search for pediatric tumor antigens. J. Immunother. 24, 281–282 (2001)
C.J. Melief, Cancer immunotherapy by dendritic cells. Immunity 29, 372–383 (2008)
J. Meng, J. Duan, H. Kong, L. Li, C. Wang, S. Xie, S. Chen, N. Gu, H. Xu, Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy. Small 4, 1364–1370 (2008)
T. Mocan, C. Iancu, Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubes. Int. J. Nanomed. 6, 1945 (2011)
P.L. Mottram, D. Leong, B. Crimeen-Irwin, S. Gloster, S.D. Xiang, J. Meanger, R. Ghildyal, N. Vardaxis, M. Plebanski, Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mol. Pharm. 4, 73–84 (2007)
G.M. Mutlu, G.S. Budinger, A.A. Green, D. Urich, S. Soberanes, S.E. Chiarella, G.F. Alheid, D.R. McCrimmon, I. Szleifer, M.C. Hersam, Biocompatible nanoscale dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary toxicity. Nano Lett. 10, 1664–1670 (2010)
D.T. O’Hagan, M.L. MacKichan, M. Singh, Recent developments in adjuvants for vaccines against infectious diseases. Biomol. Eng. 18, 69–85 (2001)
D. Pantarotto, C.D. Partidos, R. Graff, J. Hoebeke, J.-P. Briand, M. Prato, A. Bianco, Synthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptides. J. Am. Chem. Soc. 125, 6160–6164 (2003a)
D. Pantarotto, C.D. Partidos, J. Hoebeke, F. Brown, E. Kramer, J.-P. Briand, S. Muller, M. Prato, A. Bianco, Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem. Biol. 10, 961–966 (2003b)
D.A. Scheinberg, C.H. Villa, F.E. Escorcia, M.R. McDevitt, Conscripts of the infinite armada: systemic cancer therapy using nanomaterials. Nat. Rev. Clin. Oncol. 7, 266 (2010)
P. Singh, S. Campidelli, S. Giordani, D. Bonifazi, A. Bianco, M. Prato, Organic functionalisation and characterisation of single-walled carbon nanotubes. Chem. Soc. Rev. 38, 2214–2230 (2009)
P.K. Srivastava, A. Menoret, S. Basu, R.J. Binder, K.L. McQuade, Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8, 657–665 (1998)
R.M. Steinman, J. Banchereau, Taking dendritic cells into medicine. Nature 449, 419 (2007)
C.H. Villa, T. Dao, I. Ahearn, N. Fehrenbacher, E. Casey, D.A. Rey, T. Korontsvit, V. Zakhaleva, C.A. Batt, M.R. Philips, Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens. ACS Nano 5, 5300–5311 (2011)
S.D. Xiang, K. Scalzo-Inguanti, G. Minigo, A. Park, C.L. Hardy, M. Plebanski, Promising particle-based vaccines in cancer therapy. Expert. Rev. Vaccines 7, 1103–1119 (2008)
N. Yandar, G. Pastorin, M. Prato, A. Bianco, M.E. Patarroyo, J.M. Lozano, Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model. Vaccine 26, 5864–5873 (2008)
M. Zeinali, M. Jammalan, S.K. Ardestani, N. Mosaveri, Immunological and cytotoxicological characterization of tuberculin purified protein derivative (PPD) conjugated to single-walled carbon nanotubes. Immunol. Lett. 126, 48–53 (2009)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Hasnain, M.S., Nayak, A.K. (2019). Carbon Nanotubes in Vaccine Delivery. In: Carbon Nanotubes for Targeted Drug Delivery. SpringerBriefs in Applied Sciences and Technology. Springer, Singapore. https://doi.org/10.1007/978-981-15-0910-0_12
Download citation
DOI: https://doi.org/10.1007/978-981-15-0910-0_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0909-4
Online ISBN: 978-981-15-0910-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)